Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recessive Dystrophic Epidermolysis Bullosa (RDEB)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00533572
What this trial is testing

Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer

Who this might be right for
Epidermolysis Bullosa Dystrophica
Stanford University 1
Testing effectiveness (Phase 2)UnknownNCT02323789
What this trial is testing

Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
King's College London 10
Testing effectiveness (Phase 2)Looking for participantsNCT06834035
What this trial is testing

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis BullosaEpidermolysis Bullosa AcquisitaDystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 8
Testing effectiveness (Phase 2)Study completedNCT03786237
What this trial is testing

Rigosertib for RDEB-SCC

Who this might be right for
Epidermolysis Bullosa DystrophicaSquamous Cell Carcinoma
Prof. Johann Bauer 2
Not applicableUnknownNCT04285294
What this trial is testing

Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Assistance Publique - Hôpitaux de Paris 66
Very early researchActive Not RecruitingNCT04171661
What this trial is testing

Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
CHU de Quebec-Universite Laval 1
Testing effectiveness (Phase 2)UnknownNCT05529134
What this trial is testing

Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene

Who this might be right for
Dystrophic Epidermolysis Bullosa
Phoenicis Therapeutics 8
Testing effectiveness (Phase 2)Study completedNCT03752905
What this trial is testing

A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Phoenix Tissue Repair, Inc. 12
Not applicableLooking for participantsNCT01019148
What this trial is testing

Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
Stanford University 70
Not applicableStudy completedNCT01716169
What this trial is testing

Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care

Who this might be right for
Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa
Stanford University 10
Testing effectiveness (Phase 2)UnknownNCT03392909
What this trial is testing

Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
University of Southern California 9
Not applicableStudy completedNCT01874769
What this trial is testing

Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Institut National de la Santé Et de la Recherche Médicale, France 30
Not applicableLooking for participantsNCT07700966
What this trial is testing

A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics, Inc 250
Testing effectiveness (Phase 2)Ended earlyNCT02810951
What this trial is testing

FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis Bullosa Dystrophica, Recessive
Castle Creek Biosciences, LLC. 6
Very early researchEnded earlyNCT00881556
What this trial is testing

Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis Bullosa
Columbia University 3
Not applicableNot Yet RecruitingNCT07684105
What this trial is testing

Treatment of Dysphagia in Patients With Dystrophic Epidermolysis Bullosa With Budesonide: a Retrospective Bicentric Study Nice - Paris St Louis / Necker (EBUDE Study)

Who this might be right for
Recessive Dystrophic Epidermolysis BullosaDysphagiaEsophageal Stenosis
Centre Hospitalier Universitaire de Nice 15
Large-scale testing (Phase 3)Active Not RecruitingNCT04213261
What this trial is testing

FCX-007 for Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Castle Creek Biosciences, LLC. 6
Not applicableUnknownNCT06177353
What this trial is testing

Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro

Who this might be right for
Epidermolysis Bullosa Dystrophica
Assistance Publique - Hôpitaux de Paris 30
Large-scale testing (Phase 3)Study completedNCT04227106
What this trial is testing

Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics, Inc 11
Testing effectiveness (Phase 2)Looking for participantsNCT04173650
What this trial is testing

MSC EVs in Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Aegle Therapeutics 8
Next Page